AndyJMinnMD
Radiation Oncology • Philadelphia, PAAssistant Professor, Radiation Oncology, Perelman School of Medicine
Are you Dr. Minn?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
TRC 2 West
Philadelphia, PA 19104Phone+1 215-662-2428
Summary
- Dr. Andy Minn, MD is a radiation oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Jersey, and Illinois. He is affiliated with Hospital of the University of Pennsylvania, Philadelphia Veterans Affairs Medical Center, and Penn Presbyterian Medical Center.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2001 - 2005
Louis A Weiss Memorial HospitalInternship, Internal Medicine, 2000 - 2001
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2000
Certifications & Licensure
PA State Medical License 2010 - 2024
NJ State Medical License 2011 - 2015
IL State Medical License 2000 - 2011- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 133 citationsRAD51 Up-regulation Bypasses BRCA1 Function and Is a Common Feature of BRCA1-Deficient Breast TumorsRichard W. Martin, Brian J. Orelli, Mitsuyoshi Yamazoe, Andy J. Minn, Shunichi Takeda
Cancer Research. 2007-10-15 - 3310 citationsTumour exosome integrins determine organotropic metastasisAyuko Hoshino, Bruno Costa-Silva, Tang-Long Shen, Gonçalo Rodrigues, Ayako Hashimoto
Nature. 2015-11-19 - 30 citationsαB-crystallin Expression in Breast Cancer is Associated with Brain MetastasisK. David Voduc, Torsten O. Nielsen, Charles M. Perou, J. Chuck Harrell, Cheng Fan
NPJ Breast Cancer. 2015-10-21
Press Mentions
Drug Combo JAKs up Immunotherapy in Two Clinical TrialsAugust 8th, 2024- New Cancer Vaccine Bludgeons a Tumor’s Defenses Better Than EverMay 25th, 2022
- Researchers Engineer CAR T Cells to Enhance Their FunctionSeptember 7th, 2021
- Join now to see all
